CATX

Perspective TherapeuticsD

NYSE American / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-03

View Chart

Peers tracked

U.S. public peers

Grade Position

Below peers

vs peer average

CATX vs peer average

24/100

CATX vs. peer average (D vs. B)

Grade spread

A 3 · B 5 · C 1 · F 2

Graded peers loaded

Coverage

11 graded

100% of tracked

Peer overview

EDIT is the first available peer comparator.

Small-cap development-stage biotech where sentiment is heavily shaped by clinical progress, regulatory milestones, and capital runway; a reasonable risk-appetite comparator.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerEDITEditas Medicine

CATX

Perspective Therapeutics

EDIT

Editas Medicine

Grade

Momentum

Value

Sentiment

Setup Bias

Net Neutral

Market Cap

Posture

Defensive

Constructive

Open Side-by-Side Comparison Compare all

Grade position vs EDIT

CATX / EDIT

Grade Position

Below peers

CATX vs. peer average (D vs. B)

24/100

Momentum

EDIT

Value

CATX

Sentiment

CATX

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs CATX

EDIT

80/100

-2

TNXP

20/100

CCCC

80/100

-2

MNPR

Monopar Therapeutics Inc Common

100/100

-3

NGNE

Neurogene Inc Common

80/100

-2

EDIT is the first peer returned for this comparison set.